Trade JnJ ^JNJ

Farmers Trust Co. Buys 6,233 Shares of Johnson & Johnson $JNJ

Jim Cramer on Johnson & Johnson: "It's a Textbook Slowdown Stock"

Protagonist Therapeutics Soars as FDA Approves ICOTYDE for Plaque Psoriasis, Triggers $50M Milestone - Daily Political

Union Bancaire Privee UBP SA Has $33.66 Million Stake in Johnson & Johnson $JNJ - Markets Daily

Monte Rosa J J Supply Deal Refocuses MRT 2359 Prostate Cancer Story

Top Healthcare Stocks To Research - March 21st - Daily Political

Johnson & Johnson $JNJ Stock Holdings Lifted by Park National Corp OH

Park Avenue Securities LLC Acquires 23,337 Shares of Johnson & Johnson $JNJ

GoalVest Advisory LLC Has $1.33 Million Position in Johnson & Johnson $JNJ

10,212 Shares in Johnson & Johnson $JNJ Acquired by Investment Research Partners LLC

Union Bancaire Privee UBP SA Has $33.66 Million Holdings in Johnson & Johnson $JNJ - Stock Observer

GAMMA Investing LLC Buys 7,245 Shares of Johnson & Johnson $JNJ

Johnson & Johnson $JNJ Shares Bought by AIA Group Ltd

Swiss Life Asset Management Ltd Lowers Stock Position in Johnson & Johnson $JNJ - Daily Political

GoalVest Advisory LLC Acquires 5,194 Shares of Johnson & Johnson $JNJ - Daily Political

Jacobs & Co. CA Sells 2,321 Shares of Johnson & Johnson $JNJ - Daily Political

Best Healthcare Stocks To Research - March 20th - Markets Daily

Promising Medical Stocks To Research - March 20th - Daily Political

Johnson & Johnson Prostate Cancer Trial Adds Depth To Valuation Debate

Johnson & Johnson $JNJ Stock Holdings Increased by Mirabella Financial Services LLP

Allworth Financial LP Raises Stake in Johnson & Johnson $JNJ

Is It Too Late To Consider Johnson & Johnson (JNJ) After A 49.8% One-Year Surge? - Simply Wall St News

Johnson & Johnson (NYSE:JNJ) Price Target Raised to $280.00

RIA Advisory Group LLC Has $325,000 Stock Position in Johnson & Johnson $JNJ - Stock Observer

Barclays Sees Continued Strength in Johnson & Johnson (JNJ) Pharma Business

Mirabella Financial Services LLP Has $2.62 Million Stake in Johnson & Johnson $JNJ - Daily Political

Groupama Asset Managment Sells 2,495 Shares of Johnson & Johnson $JNJ - Daily Political

GI Innovation Announces First Clinical Supply Agreement to Explore Combination Therapy for Prostate Cancer - PR Newswire APAC

Jim Cramer on Johnson & Johnson: "It Should Have Gone Higher, But It Just Shows You How Hard It Is to Buck Stagflation Theories"

Jim Cramer on How to Navigate Wednesday's Tough Tape: 7 Stocks in Focus - Insider Monkey

Barclays Boosts Johnson & Johnson (NYSE:JNJ) Price Target to $234.00

Medical Stocks To Watch Today - March 19th - Stock Observer

Investors Heavily Search Johnson & Johnson (JNJ): Here is What You Need to Know

Wilmington Savings Fund Society FSB Sells 102,362 Shares of Johnson & Johnson $JNJ - Markets Daily

Tweedy Browne Co LLC Sells 2,710 Shares of Johnson & Johnson $JNJ - Markets Daily

Portus Wealth Advisors LLC Takes $1.05 Million Position in Johnson & Johnson $JNJ - Markets Daily

Wilmington Savings Fund Society FSB Sells 102,362 Shares of Johnson & Johnson $JNJ - Stock Observer

4,385 Shares in Johnson & Johnson $JNJ Purchased by ARQ Wealth Advisors LLC

Johnson & Johnson $JNJ Shares Purchased by Achmea Investment Management B.V.

2 Reasons to Buy Johnson & Johnson Stock Like There's No Tomorrow - AOL

Portus Wealth Advisors LLC Takes Position in Johnson & Johnson $JNJ - Stock Observer

Does FDA Approval Of Oral Psoriasis Drug ICOTYDE Reshape The Bull Case For Johnson & Johnson (JNJ)? - Simply Wall St News

HSBC Sees Healthcare Strength, Lifts Johnson & Johnson (JNJ) Price Target

ICOTYDE Approval Adds New Growth Angle To Johnson & Johnson Valuation Story

J&J Unit Urges Court to Set Aside $1.6 Billion Fraud Judgment

Top Healthcare Stocks To Follow Today - March 18th - Markets Daily

Icotyde psoriasis pill from J&J to rival Tremfya Skyrizi IL-23 shots

J&J, Protagonist win clearance for Icotyde in plaque psoriasis | BioWorld

US FDA approves J&J's oral psoriasis pill

ICOTYDE is the first and only IL-23R targeted oral peptide t

Johnson & Johnson Says FDA OKs ICOTYDE, First Oral IL-23 Receptor Antagonist For Plaque Psoriasis

Danske Bank A S Makes New $367.47 Million Investment in Johnson & Johnson $JNJ

Johnson & Johnson $JNJ is Livforsakringsbolaget Skandia Omsesidigt's 9th Largest Position

Captrust Financial Advisors Purchases 4,375 Shares of Johnson & Johnson $JNJ

1,981,807 Shares in Johnson & Johnson $JNJ Acquired by Danske Bank A S - Stock Observer

Icotyde's in; wave of switchers to oral psoriasis Protagonist? | BioWorld

Barbarian Taps R/GA Vet Tier To Develop New Integrated Offering 03/18/2026

Assessing Johnson & Johnson (JNJ) Valuation After Recent Share Price Pullback - Simply Wall St News

Oncology Reliance And MedTech Execution Will Threaten Long Term Earnings Stability

Johnson & Johnson (NYSE:JNJ) Sees Significant Growth in Short Interest

Johnson & Johnson (NYSE:JNJ) Stock Price Down 2.1% - Here's What Happened

Healthcare Stocks To Consider - March 17th - Markets Daily

Johnson & Johnson (NYSE:JNJ) Given New $280.00 Price Target at HSBC

Johnson & Johnson (JNJ) Forecast: Extended Rally Signals Patience for Buyers

Why One Analyst Thinks Johnson & Johnson Reaches $280 - AOL

Mariner LLC Buys 50,593 Shares of Johnson & Johnson $JNJ

Mairs & Power Inc. Trims Stake in Johnson & Johnson $JNJ

Mairs & Power Inc. Sells 24,967 Shares of Johnson & Johnson $JNJ

Moors & Cabot Inc. Has $22.60 Million Holdings in Johnson & Johnson $JNJ

Mercer Global Advisors Inc. ADV Buys 64,373 Shares of Johnson & Johnson $JNJ

Johnson & Johnson $JNJ Shares Bought by Moneta Group Investment Advisors LLC - Markets Daily

Fred Alger Management LLC Acquires 7,871 Shares of Johnson & Johnson $JNJ

Mestag Therapeutics Announces $40 Million Financing and Appoints Chief Medical Officer and Chief Development Officer in Preparation to Enter the Clinic

9,150 Shares in Johnson & Johnson $JNJ Bought by Marshall Investment Management LLC - Daily Political

Does Monte Rosa (GLUE)-J&J ERLEADA Supply Deal Reframe GLUE's MYC Degrader Investment Story? - Simply Wall St News

Mestag $40m raise takes cash haul to date to $95m and fuels new growth

Is It Time To Reassess Johnson & Johnson (JNJ) After Strong Multi Year Share Price Gains

Johnson & Johnson (JNJ) Targets Opportunities around Multiple Myeloma with TECVAYLI

Volatility has boosted dividend stocks. These are one firm's favorites

Healthcare Stocks To Follow Now - March 16th - Markets Daily

Focus Partners Wealth Has $240.15 Million Holdings in Johnson & Johnson $JNJ - Markets Daily

Jain Global LLC Buys New Holdings in Johnson & Johnson $JNJ

Bollard Group LLC Boosts Stake in Johnson & Johnson $JNJ - Markets Daily

Johnson & Johnson $JNJ Shares Sold by Hamlin Capital Management LLC

Johnson & Johnson $JNJ Position Increased by Gotham Asset Management LLC

Johnson & Johnson $JNJ Shares Sold by Fayez Sarofim & Co

EagleClaw Capital Managment LLC Acquires 3,805 Shares of Johnson & Johnson $JNJ - Markets Daily

Focus Partners Wealth Acquires 37,682 Shares of Johnson & Johnson $JNJ - Stock Observer

Johnson & Johnson $JNJ Holdings Raised by Elevation Point Wealth Partners LLC

Capitolis Liquid Global Markets LLC Cuts Stock Holdings in Johnson & Johnson $JNJ - Markets Daily

AI Podcast: Dollar Weakness and Investment Implications

HSBC: Three 'Painful Trade' Risks Loom if Wall Street Gets It Wrong

Week ahead: ECB set to cut as Wall Street earnings season gathers pace

Week ahead: US earnings season kicks off, ECB hold expected

Europe Tries to Ride on US Coat-tails

Week ahead: ECB, BoJ rate decisions + Tesla earnings on tap

Week ahead: Tesla tops Wall Street earnings bill

Zelenskyy Expresses Doubts About Budapest as Venue for Ukraine Peace Talks

Europe Rallies Behind Ukraine Amid Trump Pressure, Eyes Frozen Russian Assets

US Government Shutdown: Economic Fallout and Political Impasse

Gold Price Surge Fueled by Fed Rate Cut Expectations and Economic Uncertainty

Global Market Overview: Precious Metals Surge Amidst Economic Uncertainty

Japan LDP-Ishin Policy Talks: Paving the Way for a New Prime Minister?

Israel Prepares to Reopen Rafah Crossing Amid Ceasefire Violation Claims

Fed's Rate Cut Conundrum: An Outlook to 2026